Trial Profile
A prospective, randomized controlled trial to evaluate the efficacy and safety of combination therapy with adapalene 0.1% gel and ketoconazole 2% cream versus ketoconazole 2% cream monotherapy in patients with pityriasis versicolor
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Feb 2016
Price :
$35
*
At a glance
- Drugs Adapalene (Primary) ; Ketoconazole (Primary)
- Indications Pityriasis versicolor
- Focus Therapeutic Use
- 02 Feb 2016 New trial record